CareDx, Inc
CDNA
$18.92
$0.522.83%
| Weiss Ratings | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C | |||
| Rating Factors | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.77 | |||
| Price History | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.46% | |||
| 30-Day Total Return | -17.16% | |||
| 60-Day Total Return | -21.75% | |||
| 90-Day Total Return | -16.28% | |||
| Year to Date Total Return | -12.08% | |||
| 1-Year Total Return | 71.69% | |||
| 2-Year Total Return | 93.26% | |||
| 3-Year Total Return | -32.88% | |||
| 5-Year Total Return | 11.26% | |||
| 52-Week High % Change | -47.19% | |||
| 52-Week Low % Change | 147.98% | |||
| Price | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $34.84 | |||
| 52-Week Low Price | $7.42 | |||
| 52-Week Low Price (Date) | Apr 26, 2024 | |||
| 52-Week High Price (Date) | Aug 19, 2024 | |||
| Valuation | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.02B | |||
| Enterprise Value | 787.55M | |||
| Price/Earnings (TTM) | 21.60 | |||
| Earnings Per Share (TTM) | 0.85 | |||
| Earnings Per Share Growth | -123.99% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.21 | |||
| Price/Book (Q) | 2.66 | |||
| Enterprise Value/Revenue (TTM) | 2.36 | |||
| Price | $18.92 | |||
| Enterprise Value/EBITDA (TTM) | -19.91 | |||
| Enterprise Value/EBIT | -14.65 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 58.22M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 287 2300 | |||
| Address | 8000 Marina Boulevard South San Francisco, CA 94005 | |||
| Website | caredx.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -16.10% | |||
| Profit Margin | 15.74% | |||
| Management Effectiveness | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.01% | |||
| Return on Equity | 16.43% | |||
| Income Statement | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 333.79M | |||
| Total Revenue (TTM) | 333.79M | |||
| Revenue Per Share | $5.73 | |||
| Gross Profit (TTM) | 224.16M | |||
| EBITDA (TTM) | -39.56M | |||
| EBIT (TTM) | -53.75M | |||
| Net Income (TTM) | 52.55M | |||
| Net Income Avl. to Common (TTM) | 52.55M | |||
| Total Revenue Growth (Q YOY) | 32.04% | |||
| Earnings Growth (Q YOY) | 166.06% | |||
| EPS Diluted (TTM) | 0.85 | |||
| EPS Diluted Growth (Q YOY) | 160.76% | |||
| Balance Sheet | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 260.65M | |||
| Cash Per Share (Q) | $4.48 | |||
| Total Current Assets (Q) | 351.83M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 378.43M | |||
| Current Ratio (Q) | 3.937 | |||
| Book Value Per Share (Q) | $6.91 | |||
| Total Assets (Q) | 491.05M | |||
| Total Current Liabilities (Q) | 89.37M | |||
| Total Debt (Q) | 28.37M | |||
| Total Liabilities (Q) | 112.62M | |||
| Total Common Equity (Q) | 378.43M | |||
| Cash Flow | CDNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -483.00K | |||
| Cash from Financing (TTM) | -5.61M | |||
| Net Change in Cash (TTM) | 32.49M | |||
| Levered Free Cash Flow (TTM) | 44.34M | |||
| Cash from Operations (TTM) | 38.05M | |||
